Dabomb Protein (6578) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.013x

Based on the latest financial reports, Dabomb Protein (6578) has a cash flow conversion efficiency ratio of -0.013x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-13.86 Million ≈ $-436.60K USD) by net assets (NT$1.03 Billion ≈ $32.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Dabomb Protein - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Dabomb Protein's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 6578 total liabilities for a breakdown of total debt and financial obligations.

Dabomb Protein Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dabomb Protein ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Display Tech Co. Ltd
KQ:066670
0.068x
Culp, Inc. Common Stock
NYSE:CULP
-0.022x
INmune Bio Inc
NASDAQ:INMB
-0.214x
Werewolf Therapeutics Inc
NASDAQ:HOWL
-0.512x
TNR Gold Corp.
V:TNR
-1.253x
Westport Fuel Systems Inc
TO:WPRT
0.007x
Carelabs Co.Ltd
KQ:263700
-0.027x
Nam Hwa Construction Co.Ltd
KQ:091590
-0.020x

Annual Cash Flow Conversion Efficiency for Dabomb Protein (2015–2024)

The table below shows the annual cash flow conversion efficiency of Dabomb Protein from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Dabomb Protein market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 NT$1.09 Billion
≈ $34.32 Million
NT$47.55 Million
≈ $1.50 Million
0.044x +542.86%
2023-12-31 NT$958.06 Million
≈ $30.18 Million
NT$6.51 Million
≈ $204.97K
0.007x -74.94%
2022-12-31 NT$727.20 Million
≈ $22.91 Million
NT$19.71 Million
≈ $620.85K
0.027x +141.29%
2021-12-31 NT$674.24 Million
≈ $21.24 Million
NT$-44.25 Million
≈ $-1.39 Million
-0.066x -442.83%
2020-12-31 NT$700.51 Million
≈ $22.07 Million
NT$13.41 Million
≈ $422.52K
0.019x -59.80%
2019-12-31 NT$698.39 Million
≈ $22.00 Million
NT$33.26 Million
≈ $1.05 Million
0.048x +53.30%
2018-12-31 NT$710.52 Million
≈ $22.39 Million
NT$22.07 Million
≈ $695.42K
0.031x -55.90%
2017-12-31 NT$622.77 Million
≈ $19.62 Million
NT$43.87 Million
≈ $1.38 Million
0.070x -26.73%
2016-12-31 NT$619.77 Million
≈ $19.53 Million
NT$59.58 Million
≈ $1.88 Million
0.096x -59.24%
2015-12-31 NT$592.64 Million
≈ $18.67 Million
NT$139.78 Million
≈ $4.40 Million
0.236x --

About Dabomb Protein

TWO:6578 Taiwan Packaged Foods
Market Cap
$34.79 Million
NT$1.10 Billion TWD
Market Cap Rank
#23203 Global
#1462 in Taiwan
Share Price
NT$15.35
Change (1 day)
-2.54%
52-Week Range
NT$15.35 - NT$25.55
All Time High
NT$32.11
About

DaBomb Protein Biotech Corp. manufactures and sells hydrolyzed soy protein in Vietnam, the Philippines, South Korea, Taiwan, and Asia. It offers plant protein, including DaBomb-P (Aqua) and DaBomb-P (Livestock); antibiotics alternatives, such as DBT-100 HT and DBT-100 LS; and pet care products comprising Liqui-TIDE bandages. The company was formerly known as DaBomb Protein Corp. and changed its n… Read more